About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Skp1tm1.2Jw
targeted mutation 1.2, Jeremy Wang
MGI:6455735
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Skp1tm1.1Jw/Skp1tm1.2Jw
Tg(Ddx4-cre)1Dcas/0
involves: 129S4/SvJae * C57BL/6 * FVB MGI:6455745
cn2
Skp1tm1.1Jw/Skp1tm1.2Jw
Tg(Ddx4-cre/ERT2)1Dcas/0
involves: 129S4/SvJae * C57BL/6 * FVB/N MGI:6455746


Genotype
MGI:6455745
cn1
Allelic
Composition
Skp1tm1.1Jw/Skp1tm1.2Jw
Tg(Ddx4-cre)1Dcas/0
Genetic
Background
involves: 129S4/SvJae * C57BL/6 * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Skp1tm1.1Jw mutation (0 available); any Skp1 mutation (18 available)
Skp1tm1.2Jw mutation (0 available); any Skp1 mutation (18 available)
Tg(Ddx4-cre)1Dcas mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular

reproductive system




Genotype
MGI:6455746
cn2
Allelic
Composition
Skp1tm1.1Jw/Skp1tm1.2Jw
Tg(Ddx4-cre/ERT2)1Dcas/0
Genetic
Background
involves: 129S4/SvJae * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Skp1tm1.1Jw mutation (0 available); any Skp1 mutation (18 available)
Skp1tm1.2Jw mutation (0 available); any Skp1 mutation (18 available)
Tg(Ddx4-cre/ERT2)1Dcas mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• at 4 months in tamoxifen-treated mice despite being present at 2 months
• precocious chromosomal desynapsis in the female and male germ cells of tamoxifen-treated mice
• misalignment of chromosomes in the oocytes of tamoxifen treated mice
• progressive in tamoxifen-treated mice
• severe in tamoxifen-treated mice with absent metaphase spermatocytes
• absent metaphase spermatocytes and postmeiotic spermatids in tamoxifen-treated mice
• precocious chromosomal desynapsis and pachytene exit leading to absent metaphase spermatocytes in tamoxifen-treated mice
• in tamoxifen-treated mice

homeostasis/metabolism
• impaired meiotic recombination in spermatocytes and oocytes of tamoxifen-treated mice

endocrine/exocrine glands
• progressive in tamoxifen-treated mice

cellular
• at 4 months in tamoxifen-treated mice despite being present at 2 months
• absent metaphase spermatocytes and postmeiotic spermatids in tamoxifen-treated mice
• precocious chromosomal desynapsis in the female and male germ cells of tamoxifen-treated mice
• misalignment of chromosomes in the oocytes of tamoxifen treated mice
• precocious chromosomal desynapsis and pachytene exit leading to absent metaphase spermatocytes in tamoxifen-treated mice
• impaired meiotic recombination in spermatocytes and oocytes of tamoxifen-treated mice
• in vitro fertilized oocytes fail to sustain preimplantation embryonic development





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory